Sector evidence · 38 records
Biotech & techbio
Companies may carry more than one sector label. This page only exists because at least three records share this classification.
| Company | Latest stage | Sector | Location | Latest date |
|---|---|---|---|---|
| Isomorphic Labs | Series B | AI / ML / data; Biotech & techbio | London | 2026-05-01 |
| Tropic Biosciences | Series C | Biotech & techbio | Norwich | 2026-03-01 |
| Nuclera | Series C | Biotech & techbio | Cambridge | 2026-01-01 |
| Artios Pharma | Series D | Biotech & techbio | Cambridge | 2025-11-01 |
| Charm Therapeutics | Series B | Biotech & techbio | London | 2025-09-01 |
| Lindus Health | Series B | Biotech & techbio; Healthtech & digital health | London | 2025-01-21 |
| Basecamp Research | Series B | AI / ML / data; Biotech & techbio | London | 2024-10-09 |
| Enara Bio | Series B | Biotech & techbio | Oxford | 2024-10-01 |
| Purespring Therapeutics | Series B | Biotech & techbio | London | 2024-10-01 |
| Healx | Series C | Biotech & techbio; Healthtech & digital health | Cambridge | 2024-08-01 |
| Beacon Therapeutics | Series B | Biotech & techbio | London (dual HQ with Cambridge, Massachusetts, US - verify UK-HQ eligibility before use) | 2024-07-01 |
| Bicycle Therapeutics | Private placement | Biotech & techbio | Cambridge | 2024-05-23 |
| LabGenius | Series B | Biotech & techbio | London | 2024-05-01 |
| Biofidelity | Series B | Biotech & techbio | Cambridge | 2024-04-01 |
| Mission Therapeutics | Series D | Biotech & techbio | Cambridge | 2024-03-01 |
| Apollo Therapeutics | Series C (second close) | Biotech & techbio | Cambridge | 2024-01-02 |
| Pheon Therapeutics | Series B | Biotech & techbio | Manchester | 2024-01-01 |
| Sitryx Therapeutics | Series B | Biotech & techbio | Oxford | 2023-09-01 |
| Causaly | Series B | AI / ML / data; Biotech & techbio | London | 2023-07-13 |
| OMass Therapeutics | Series B | Biotech & techbio | Oxford | 2023-05-01 |
| Crescendo Biologics | Series C | Biotech & techbio | Cambridge | 2023-01-01 |
| Grey Wolf Therapeutics | Series B | Biotech & techbio | Oxford | 2023-01-01 |
| Pulmocide | Series C | Biotech & techbio | London | 2023-01-01 |
| Storm Therapeutics | Series B | Biotech & techbio | Cambridge | 2022-12-01 |
| MiroBio | Series B | Biotech & techbio | Oxford | 2022-06-01 |
| Colorifix | Series B | Biotech & techbio | Norwich | 2022-05-01 |
| Microbiotica | Series B | Biotech & techbio | Cambridge | 2022-03-07 |
| InstaDeep | Series B | Biotech & techbio | London (dual HQ with Tunis, Tunisia) | 2022-01-01 |
| Quell Therapeutics | Series B | Biotech & techbio | London | 2021-11-01 |
| Lifebit Biotech | Series B | Biotech & techbio; AI / ML / data; Devtools / cloud / infra | London | 2021-09-28 |
| Touchlight | Series B (extended round) | Biotech & techbio | Hampton, Middlesex (Greater London) | 2021-09-15 |
| PetMedix | Series B | Biotech & techbio | Cambridge | 2021-09-01 |
| Exscientia | Series D | Biotech & techbio | Oxford | 2021-04-01 |
| Evox Therapeutics | Series C | Biotech & techbio | Oxford | 2021-02-01 |
| Genomics plc | Series B | Biotech & techbio | Oxford | 2021-01-01 |
| Congenica | Series C | Healthtech & digital health; Biotech & techbio | Cambridge | 2020-11-01 |
| Better Dairy | Portfolio stage not normalized | Biotech & techbio; Climate / energy / cleantech; Foodtech / agritech | London | Not stated |
| Ochre Bio | Portfolio stage not normalized | Biotech & techbio; Healthtech & digital health | London | Not stated |